The Regulatory Affairs and Quality Assurance Team at QurAlis is responsible for ensuring that all therapeutic developments meet regulatory standards and quality benchmarks throughout the drug development process. This team collaborates closely with clinical and research teams to navigate the regulatory landscape, prepare necessary documentation for submissions, and implement quality assurance measures that uphold Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Their work is critical in facilitating the advancement of precision therapeutics for ALS while ensuring compliance and safety.